MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-14-2025
ENDRA Life Sciences Operating Cash Flow 2011-2026 | NDRA
Annual Operating Cash Flow ENDRA Life Sciences
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.4 M | -9.55 M | -12.8 M | -11.1 M | -10.7 M | -8.59 M | -7.7 M | -3.3 M | -1.32 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -1.32 M | -12.8 M | -8.06 M |
Quarterly Operating Cash Flow ENDRA Life Sciences
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | -1.29 M | - | - | - | -2.14 M | - | - | - | -2.51 M | - | -9.68 M | -6.43 M | -3.1 M | - | -8.47 M | -5.72 M | -2.92 M | - | -8.67 M | -6.54 M | -3.09 M | - | -6.68 M | -4.2 M | -2.54 M | - | -5.8 M | -4.33 M | -2.45 M | - | -1.93 M | -1.38 M | -236 K | - | -769 K | -769 K | -53.8 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -53.8 K | -9.68 M | -3.82 M |
Operating Cash Flow of other stocks in the Diagnostics research industry
| Issuer | Operating Cash Flow | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Bioventus
BVS
|
74.7 M | $ 8.99 | 1.35 % | $ 599 M |  USA |
 |
Brainsway Ltd.
BWAY
|
884 K | $ 13.73 | 0.59 % | $ 99.4 M |  Israel |
 |
Castle Biosciences
CSTL
|
64.9 M | $ 25.9 | 0.27 % | $ 719 M | USA |
 |
Aspira Women's Health
AWH
|
-32.2 M | - | -6.19 % | $ 10.5 M | USA |
 |
DexCom
DXCM
|
1.44 B | $ 67.32 | 1.48 % | $ 26.3 B | USA |
 |
Guardant Health
GH
|
-185 M | $ 88.75 | 1.8 % | $ 11.1 B | USA |
 |
Charles River Laboratories International
CRL
|
738 M | $ 153.71 | 1.14 % | $ 7.62 B | USA |
 |
CareDx, Inc
CDNA
|
42 M | $ 17.6 | 1.62 % | $ 938 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-48.7 M | - | -61.36 % | $ 2.46 M | USA |
 |
Exact Sciences Corporation
EXAS
|
491 M | $ 103.94 | 0.09 % | $ 19.6 B | USA |
 |
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M |  China |
 |
Genetic Technologies Limited
GENE
|
-5.66 M | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-524 M | - | 0.12 % | $ 80.1 M | China |
 |
Fulgent Genetics
FLGT
|
21.1 M | $ 15.43 | 3.21 % | $ 467 M | USA |
|
Biodesix
BDSX
|
-48.6 M | $ 16.59 | -4.05 % | $ 2.15 B | USA |
 |
ICON Public Limited Company
ICLR
|
1.29 B | $ 100.49 | 2.95 % | $ 8.29 B |  Irlanda |
 |
Anixa Biosciences
ANIX
|
-7.17 M | $ 2.89 | 1.76 % | $ 93.8 K | USA |
 |
IQVIA Holdings
IQV
|
2.65 B | $ 168.43 | 2.15 % | $ 29 B | USA |
 |
Danaher Corporation
DHR
|
6.42 B | $ 195.21 | 2.0 % | $ 139 B | USA |
 |
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | USA |
 |
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | USA |
 |
Pacific Biosciences of California
PACB
|
-111 M | $ 1.38 | 1.47 % | $ 414 M | USA |
 |
Illumina
ILMN
|
837 M | $ 120.84 | 1.31 % | $ 19.2 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.89 B | $ 198.61 | -0.17 % | $ 22 B | USA |
 |
QIAGEN N.V.
QGEN
|
674 M | - | - | $ 10.6 B |  Niderland |
 |
Agilent Technologies
A
|
1.48 B | $ 112.75 | 0.82 % | $ 34.3 B | USA |
 |
BioNano Genomics
BNGO
|
-68.9 M | $ 1.13 | 1.8 % | $ 1.44 M | USA |
 |
DarioHealth Corp.
DRIO
|
-30.4 M | $ 8.75 | 3.92 % | $ 248 M | Israel |
 |
NeoGenomics
NEO
|
5.23 M | $ 8.27 | 0.36 % | $ 1.06 B | USA |
 |
Neogen Corporation
NEOG
|
58.2 M | $ 9.27 | 1.76 % | $ 2.01 B | USA |
 |
Lantheus Holdings
LNTH
|
390 M | $ 80.45 | 2.48 % | $ 5.43 B | USA |
 |
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-8 M | - | - | $ 9.42 M | Israel |
 |
Co-Diagnostics
CODX
|
-22.1 M | $ 4.4 | 101.83 % | $ 129 M | USA |
 |
Medpace Holdings
MEDP
|
713 M | $ 455.15 | 0.33 % | $ 13.1 B | USA |
 |
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K | Israel |
 |
Mettler-Toledo International
MTD
|
956 M | $ 1 206.72 | 0.63 % | $ 24.9 B |  Schweiz |
 |
Celcuity
CELC
|
-83.5 M | $ 114.11 | -0.69 % | $ 4.5 B | USA |
 |
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | USA |
 |
National Research Corporation
NRC
|
26.4 M | $ 17.73 | 1.9 % | $ 397 M | USA |
 |
Twist Bioscience Corporation
TWST
|
-47.6 M | $ 47.28 | 5.04 % | $ 2.83 B | USA |
 |
Invitae Corporation
NVTA
|
-493 M | - | - | $ 21.2 M | USA |
 |
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | USA |
 |
Natera
NTRA
|
-432 M | $ 198.38 | 0.35 % | $ 19.5 B | USA |